Endovascular electrolytically detachable guidewire tip
Abstract
A guidewire (10,42) for use in endovascular electrothrombosis in combination with a microcatheter (44), the guidewire comprising: a core wire having a main body (12,16;32) and a distal portion (18,26;36,46); anda coil (28,56) coupled to said main body (12,16,32) via said distal portion (18,26,36,46) and comprised of material not susceptible to electrolytic disintegration in blood, said coil (28,56) containing no internal reinforcement and being for endovascular insertion within a vascular cavity; wherein said distal portion (18,26,36,46) is susceptible to electrolytic disintegration in blood whereby, on the application of current to the guidewire (10,42) when said coil (28,56) is disposed in the vascular cavity, endovascular electrothrombosis can be performed and at least one portion of said distal portion (18,26,36,46) electrolytically disintegrated to detach said coil (28,56) from said main body (12,16,32).

Term
Term ended
Projected expiry passed 3 January 2011, 15.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
26 claims: 17 independent, 9 dependent
- 1A guidewire (10,42) for use in endovascular electrothrombosis in combination with a microcatheter (44), the guidewire comprising:a core wire having a main body (12,16;32) and a distal portion (18,26;36,46);and a coil (28,56) coupled to said main body (12,16,32) via said distal portion (18,26,36,46) and comprised of material not susceptible to electrolytic disintegration in blood, said coil (28,56) containing no internal reinforcement and being for endovascular insertion within a vascular cavity;wherein said distal portion (18,26,36,46) is susceptible to electrolytic disintegration in blood whereby, on the application of current to the guidewire (10,42) when said coil (28,56) is disposed in the vascular Cavity, endovascular electrothrombosis can be performed and at least one portion of said distal portion (18,26,36,46) electrolytically disintegrated to detach said coil (28,56) from said main body (12,16,32).
- 7A guidewire as claimed in any one of the preceding claims, wherein the detachable coil (28,56) is a long and pliable segment.
- 9A guidewire as claimed in any one of the preceding claims, wherein the detachable coil (28,56) is comprised of a metal not susceptible to electrolytic disintegration in blood.
- 10A guidewire as claimed in any one of the preceding claims, wherein the detachable coil (28,56) is made of platinum or platinum alloy.
- 12A guidewire as claimed in any one of the preceding claims, wherein the detachable coil (28) is prebiased to form a helix or spiral when advanced from a microcatheter into the vascular cavity.
- 16A guidewire as claimed in any one of claims 13 to 16, wherein although prebiased the detachable coil (28) is extremely soft and its overall shape is easily deformed such that, once advanced from a microcatheter into the vascular cavity, it will loosely deform to the interior shape of the vascular cavity.
- 18A guidewire as claimed in any one of the preceding claims, wherein the detachable coil (28,56) is between 0.254 and 0.508 mm in diameter.
- 19A guidewire as claimed in any one of the preceding claims, wherein the diameter of wire wound to form the detachable coil (28,56) is approximately between 0.025 and 0.125 mm.
- 20A guidewire as claimed in any one of the preceding claims, wherein the distal end of the detachable coil (28) is provided with a platinum soldered tip (30,58) to form a rounded and smooth termination to avoid puncturing the vascular cavity.
- 21A guidewire as claimed in any one of the preceding claims, wherein the core wire is between 50 and 300 cm in length.
- 22A guidewire as claimed in any one of the preceding claims, wherein the detachable coil (28,56) has a length of approximately 1 to 50 cm.
- 23A guidewire as claimed in any one of the preceding claims, wherein the main body (12,16,32) of the core wire is covered with insulation (24), to prevent the underlying portion of the guidewire from coming into contact with blood.
- 24A guidewire as claimed in any one of the preceding claims, wherein the distal portion (18,26,36,46) of the core wire is such that when the detachable coil (28,56) is disposed in the vascular cavity and the guidewire is supplied with a current of approximately 0.01 to 2 milliamps to the guidewire at 0.1 to 6 volts, electrolytic disintegration of said at least one portion of the distal portion (18,26,36,46) of the core wire takes place within 3 to 10 minutes, preferably about 4 minutes, thereby to detach the detachable coil from the main body of the core wire.
- 25A guidewire as claimed in any one of the preceding claims, wherein the vascular cavity is an intracranial aneurysm.
- 26A microcatheter (44) having disposed therein a guidewire (10,42) of the construction claimed in any one of the preceding claims.
Independent claims17
71 paragraphs, as filed
Background of the Invention
1. Field of the Invention
0001The invention relates to a method and apparatus for endovascular electrothromoic formation of thrombi in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas.
2. Description of the Prior Art
0002Approximately 25,000 intracranial aneurysms rupture every year in North America. The primary purpose of treatment for ruptured intracranial aneurysm is to prevent rebleeding. At the present time, three general methods of treatment exist, namely an extravascular, endovascular and extra-endovascular approach.
0003The extravascular approach is comprised of surgery or microsurgery of the aneurysm or treatment site for the purpose of preserving the parent artery. This treatment is common with intracranial berry aneurysms. The methodology comprises the step of clipping the neck of the aneurysm, performing a suture-ligation of the neck, or wrapping the entire aneurysm. Each of these surgical procedures is performed by intrusive invasion into the body and performed from outside the aneurysm or target site. General anesthesia, craniotomy, brain retraction and arachnoid dissection around the neck of the aneurysm and placement of a clip are typically required in these surgical procedures. Surgical treatment of vascular intracranial aneurysm can expect a mortality rate of 4-8% with a morbidity rate of 18-20%. Because of the mortality and morbidity rate expected, the surgical procedure is often delayed while waiting for the best surgical time with the result that an additional percentage of patients will die from the underlying disease or defect prior to surgery. For this reason the prior art has sought alternative means of treatment.
0004In the endovascular approach, the interior of the aneurysm is entered through the use of a microcatheter. Recently developed microcatheters, such as those shown by <b>Engleson</b>, "Catheter Guidewire", U.S. Patent 4,884,579 and as described in <b>Engleson</b>, "Catheter for Guidewire Tracking", U.S. Patent 4,739,768 (1988), allow navigation into the cerebral arteries and entry into a cranial aneurysm.
0005In such procedures a balloon is typically attached to the end of the microcatheter and it is possible to introduce the balloon into the aneurysm, inflate it, and detach it, leaving it to occlude the sac and neck with preservation of the parent artery. While endovascular balloon embolization of berry aneurysms is an attractive method in situations where an extravascular surgical approach is difficult, inflation of a balloon into the aneurysm carries some risk of aneurysm rupture due to possible over-distention of portions of the sac and due to the traction produced while detaching the balloon.
0006While remedial procedures exist for treating a ruptured aneurysm during classical extravascular surgery, no satisfactory methodology exists if the aneurysm breaks during an endovascular balloon embolization.
0007Furthermore, an ideal embolizing agent should adapt itself to the irregular shape of the internal walls of the aneurysm. On the contrary, in a balloon embolization the aneurysmal wall must conform to the shape of the balloon. This may not lead to a satisfactory result and further increases the risk of rupture.
0008Still further, balloon embolization is not always possible. If the diameter of the deflated balloon is too great to enter the intracerebral arteries, especially in the cases where there is a vasospasm, complications with ruptured intracranial aneurysms nay occur. The procedure then must be deferred until the spasm is resolved and this then incurs a risk of rebleeding.
0009In the extra-intravascular approach, an aneurysm is surgically exposed or stereotaxically reached with a probe. The wall of the aneurysm is then perforated from the outside and various techniques are used to occlude the interior in order to prevent it from rebleeding. These prior art techniques include electrothrombosis, isobutyl-cyanoacrylate embolization, hog-hair embolization and ferromagnetic thrombosis.
0010In the use of electrothrombosis for extra-intravascular treatment the tip of a positively charged electrode is inserted surgically into the interior of the aneurysm. An application of the positive charge attracts white blood cells, red blood cells, platelets and fibrinogen which are typically negatively charged at the normal pH of the blood. The thrombic mass is then formed in the aneurysm about the tip. Thereafter, the tip is removed. See <b>Mullan</b>, "Experiences with Surgical Thrombosis of Intracranial Berry Aneurysms and Carotid Cavernous Fistulas", J. Neurosurg., Vol. 41, December 1974; <b>Hosobuchi</b>, "Electrothrombosis Carotid-Cavernous Fistula", J. Neurosurg., Vol. 42, January 1975; <b>Araki</b> et al., "Electrically Induced Thrombosis for the Treatment of Intracranial Aneurysms and Angiomas", Excerpta Medica International Congress Series, Amsterdam 1965, Vol. 110, 651-654; <b>Sawyer</b> et al., "Bio-Electric Phenomena as an Etiological Factor in Intravascular Thrombosis", Am. J. Physiol., Vol. 175, 103-107 (1953); <b>J. Piton</b> et al., "Selective Vascular Thrombosis Induced by a Direct Electrical Current; Animal Experiments", J. Neuroradiology, Vol. 5, pages 139-152 (1978). However, each of these techniques involves some type of intrusive procedure to approach the aneurysm from the exterior of the body.
0011The prior art has also devised the use of a liquid adhesive, isobutyl-cyanoacrylate (IBCA) which polymerizes rapidly on contact with blood to form a firm mass. The liquid adhesive is injected into the aneurysm by puncturing the sac with a small needle. In order to avoid spillage into the parent artery during IBCA injection, blood flow through the parent artery must be momentarily reduced or interrupted. Alternatively, an inflated balloon may be placed in the artery at the level of the neck of the aneurysm for injection. In addition to the risks caused by temporary blockage of the parent artery, the risks of seepage of such a polymerizing adhesive into the parent artery exists, if it is not completely blocked with consequent occlusion of the artery.
0012Still further, the prior art has utilized an air gun to inject hog hair through the aneurysm wall to induce internal thrombosis. The success of this procedure involves exposing the aneurysm sufficiently to allow air gun injection and has not been convincingly shown as successful for thrombic formations.
0013Ferromagnetic thrombosis in the prior art in extra-intravascular treatments comprises the stereotactic placement of a magnetic probe against the sac of the aneurysm followed by injection into the aneurysm by an injecting needle of iron microspheres. Aggregation of the microspheres through the extravascular magnet is followed by interneuysmatic thrombus. This treatment has not been entirely successful because of the risk of fragmentation of the metallic thrombus when the extravascular magnet is removed. Suspension of the iron powder in methyl methymethacrylate has been used to prevent fragmentation. The treatment has not been favored, because of the need to puncture the aneurysm, the risk of occlusion of the parent artery, the use of unusual and expensive equipment, the need for a craniectomy and general anesthesia, and the necessity to penetrate cerebral tissue to reach the aneurysm.
0014Endovascular coagulation of blood is also well known in the art and a device using laser optically generated heat is shown by <b>O'Reilly</b>, "Optical Fiber with Attachable Metallic Tip for Intravascular laser Coagulation of Arteries, Veins, Aneurysms, Vascular Malformation and Arteriovenous Fistulas", U.S. Patent 4,735,201 (1988). See also, <b>O'Reilly</b> et al., "Laser Induced Thermal Occlusion of Berry Aneurysms: Initial Experimental Results", Radiology, Vol. 171, No. 2, pages 471-74 (1989). <b>O'Reilly</b> places a tip into an aneurysm by means of an endovascular microcatheter. The tip is adhesively bonded to a optic fiber disposed through the microcatheter. Optical energy is transmitted along the optic fiber from a remote laser at the proximal end of the microcatheter. The optical energy heats the tip to cauterize the tissue surrounding the neck of the aneurysm or other vascular opening to be occluded. The catheter is provided with a balloon located on or adjacent to its distal end to cut off blood flow to the site to be cauterized and occluded. Normally, the blood flow would carry away the heat at the catheter tip, thereby preventing cauterization. The heat in the tip also serves to melt the adhesive used to secure the tip to the distal end of the optical fiber. If all goes well, the tip can be separated from the optical fiber and left in place in the neck of the aneurysm, provided that the cauterization is complete at the same time as the hot melt adhesive melts.
0015A thrombus is not formed from the heated tip. Instead, blood tissue surrounding the tip is coagulated. Coagulation is a denaturation of protein to form a connective-like tissue similar to that which occurs when the albumen of an egg is heated and coagulates from a clear running liquid to an opaque white solid. The tissue characteristics and composition of the coagulated tissue is therefore substantially distinct from the thrombosis which is formed by the thrombotic aggregation of white and red blood cells, platelets and fibrinogen. The coagulative tissue is substantially softer than a thrombic mass and can therefore more easily be dislodged.
0016<b>O'Reilly's</b> device depends at least in part upon the successful cauterization timed to occur no later than the detachment of the heat tip from the optic fiber. The heated tip must also be proportionally sized to the neck of the aneurysm in order to effectively coagulate the tissue surrounding it to form a blockage at the neck. It is believed that the tissue in the interior of the aneurysm remains substantially uncoagulated. In addition, the hot melt adhesive attaching the tip to the optic fiber melts and is dispersed into the adjacent blood tissue where it resolidifies to form free particles within the intracranial blood stream with much the same disadvantages which result from fragmentation of a ferromagnetic electrothrombosis.
0017Therefore, what is needed is an apparatus and methodology which avoids each of the shortcomings and limitations of the prior art discussed above.
Brief Summary of the Invention
0018A method for forming a thrombus within a vascular cavity comprising the steps of endovascularly disposing a guidewire near an endovascular opening into the vascular cavity. A distal tip of the guidewire is disposed into the vascular cavity. An electrical signal is applied to the distal tip within the vascular cavity to form a thrombus within the vascular cavity about the distal tip. The distal tip is detached from the guidewire to leave the distal tip within the vascular cavity and the thrombus electrically formed within the vascular cavity.
0019As a result, electrical formation of a thrombus is completely endovascularly formed.
0020The step of disposing the distal tip in the vascular cavity further comprises the step of substantially occupying the vascular cavity with the distal tip.
0021In one embodiment the step of substantially occupying the vascular cavity comprises the step of filling the vascular cavity with a long and pliable length of the distal tip.
0022The step of detaching the distal tip from the guidewire comprises the step of electrolytically detaching the distal tip from the guidewire.
0023The step of electrolytically detaching the distal tip from the guidewire comprises the step of electrolytically disintegrating at least one portion of a connecting segment extending between the guidewire and the distal tip.
0024The step of electrolytically disintegrating the connecting segment comprises the step of electrolytically corroding away at least a portion of a coil segment.
0025The step of electrolytically corroding the coil segment comprises the step of electrolytically disintegrating a stainless steel coil segment.
0026The step of applying an electrical signal to the distal tip to form the thrombus comprises the step of applying a positive direct current for a first predetermined time period. The tip can be detached in at least three different ways. First, the same current for forming the thrombosis may also simultaneously be used to detach the tip. Second, the current, which forms the thrombosis or initiates the continuing formation of the thrombosis during a following period of no current, is followed by a current of the same or different magnitude during a second time period to effect detachment. Third, the thrombosis is formed during a time period during which the disintegratable portion of the tip is arranged and configured not to be exposed to the blood. The guidewire is then repositioned so the disintegratable portion is exposed to electrolytic disintegration in the blood by application of the same or different level of current for an additional time period to effect detachment.
0027The invention is also a guidewire for use in electrothrombosis and used in combination with a microcatheter comprising a core wire. The core wire has a distal portion susceptible to electrolytic disintegration in blood. A tip portion is coupled to the distal portion of the core wire. The tip portion is provided for endovascular insertion within a vascular cavity.
0028As a result, endovascular electrothrombosis is achieved.
0029The distal portion is an exposed stainless steel segment.
0030The stainless steel segment comprises a coil connected at its proximate end to the core wire and connected at its distal end to the tip portion of the guidewire.
0031In one embodiment the core wire is extended in a threadlike portion concentrically within the stainless steel coil from the distal end of the stainless steel coil to where the stainless steel coil is connected to the tip portion of the guidewire.
0032In another embodiment the coil defines an interior space. The interior space is free and unreinforced.
0033The tip portion is a long and substantially pliable segment and is comprised of a material not susceptible to electrolytic disintegration within blood.
0034In one embodiment the long and pliable segment has a length sufficient to substantially fill the vascular cavity when inserted therein.
0035In another embodiment the long and pliable segment is prebiased to form a helix when extended from the microcatheter. The helix may have a conical envelope or a cylindrical envelope.
0036The invention can better be visualized by now turning to the following drawings wherein like elements are referenced by like numerals.
Brief Description of the Drawings
0037Figure 1 is an enlarged partially cross-sectioned side view of a first embodiment of the distal end of the guidewire and guidewire tip of the invention.
0038Figure 2 is an enlarged longitudinal cross section of a second embodiment of the guidewire and guidewire tip of the invention.
0039Figure 3 is an enlarged side view of a third embodiment of the invention with a microcatheter portion cut away in a longitudinal cross-sectional view.
0040Figure 4 is a simplified depiction of the guidewire of Figure 3 shown disposed within a simple cranial aneurysm.
0041Figure 5 is a depiction of the microguidewire of Figure 4 shown after electrolytic detachment of the guidewire tip.
Detailed Description of the Preferred Embodiments
0042An artery, vein, aneurysm, vascular malformation or arterial fistula is occluded through endovascular electrothrombosis by the endovascular insertion of a platinum guidewire tip into the vascular cavity followed by application of a positive current. The guidewire tip is then separated from the guidewire by electrolytic separation of the tip from the guidewire. A portion of the guidewire connected between the tip and the body of the guidewire is comprised of stainless steel and exposed to the bloodstream so that upon continued application of a positive current to the exposed portion, the exposed portion is corroded away at least at one location and the tip is separated from the body of the guidewire. The guidewire and the microcatheter are thereafter removed leaving the guidewire tip embedded in the thrombus formed within the vascular cavity.
0043Figure 1 is an enlarged side view of a first embodiment of the distal end of the guidewire and guidewire tip shown in partial cross-sectional view. A conventional Teflon laminated or similarly insulated stainless steel guidewire 10 is disposed within a protective microcatheter (not shown). Stainless steel guidewire 10 is approximately 0.010 - 0.020 inch (0.254-0.508 mm) in diameter. In the illustrated embodiment, guidewire 10 is tapered at its distal end to form a conical section 12 which joins a section 14 of reduced diameter which extends longitudinally along a length 16 of guidewire 10. Section 16 then narrows gradually down to a thin threadlike portion 18 beginning at a first bonding location 20 and ending at a second bonding location 22.
0044The stainless steel guidewire 10, comprised of that portion disposed within the microcatheter body, tapered section 12, reduced diameter section 16 and threadlike section 18, is collectively referred to as a core wire which typically is 50 - 300 cm. in length.
0045In the illustrated embodiment the portion of the core wire extending from tapered section 12 to second bonding location 22 is collectively referred to as the grinding length and may typically be between 20 and 50 cm. in length.
0046Reduced diameter portion 14 and at least part of sections 12 and first bonding location 20 may be covered with an insulating Teflon laminate 24 which encapsulizes the underlying portion of guidewire 10 to prevent contact with the blood.
0047A stainless steel coil 26 is soldered to the proximate end of threadlike portion 18 of guidewire 10 at first bonding location 20. Stainless steel coil 26 is typically 3 to 10 cm. in length and like guidewire 10 has a diameter typically between 0.010 to 0.020 inch (0.254-0.508 mm).
0048The distal end of stainless steel coil 26 is soldered to the distal end of threadlike portion 18 of guidewire 10 and to the proximal end of a platinum secondary coil 28 at second bonding location 22. Secondary coil 28 itself forms a spiral or helix typically between 2 to 10 mm. in diameter. The helical envelope formed by secondary coil 28 may be cylindrical or conical. Like guidewire 10 and stainless steel coil 26, secondary coil 28 is between approximately 0.010 and 0.020 inch (0.254-0.508 mm) in diameter. The diameter of the wire itself forming stainless steel coil 26 and coil 28 is approximately between 0.001 - 0.005 inch.
0049The distal end of secondary coil 28 is provided with a platinum soldered tip 30 to form a rounded and smooth termination to avoid puncturing the aneurysm or tearing tissue.
0050Although prebiased to form a cylindrical or conical envelope, secondary coil 28 is extremely soft and its overall shape is easily deformed. When inserted within the microcatheter (not shown), secondary coil 28 is easily straightened to lie axially within the microcatheter. Once disposed out of the tip of the microcatheter, secondary coil 28 forms the shape shown in Figure 1 and may similarly be loosely deformed to the interior shape of the aneurysm.
0051As will be described below in greater detail in connection with the third embodiment of Figure 3, after placement of secondary coil 28 within the interior of the aneurysm, a direct current is applied to guidewire 10 from a voltage source exterior to the body. The positive charge on secondary coil 28 within the cavity of the aneurysm causes a thrombus to form within the aneurysm by electrothrombosis. Detachment of the tip occurs either: (1) by continued application of current for a predetermined time when the portion 18 is exposed to blood; or (2) by movement of the wire to expose portion 18 to blood followed by continued current application for a predeteremined time. Ultimately, both threadlike portion and stainless steel coil 26 will be completely disintegrated at least at one point, thereby allowing guidewire 10 to be withdrawn from the vascular space while leaving secondary coil 28 embedded within the thrombus formed within the aneurysm.
0052Figure 2 illustrates in enlarged partially cross-sectional view a second embodiment of the invention. Stainless steel core 32 terminates in a conical distal portion 34. Stainless steel coil 36, shown in cross-sectional view, is soldered to distal portion 34 of guidewire 32 at bonding location 38. The opposing end of the stainless steel coil 36 is provided with a soldered, rounded platinum tip 40. In the illustrated embodiment, stainless steel core wire 32 is approximately 0.010 inch in diameter with the length of stainless steel coil 36 being approximately 8 cm. with the longitudinal length of platinum tip 40 being between 3 and 10 mm. The total length of guidewire 32 from tip 40 to the proximate end is approximately 150 cm.
0053The embodiment of Figure 2 is utilized in exactly the same manner as described above in connection with Figure 1 to form a thrombic mass within an aneurysm or other vascular cavity. The embodiment of Figure 2 is distinguished from that shown in Figure 1 by the absence of the extension of stainless core 32 through coil 36 to tip 40. In the case of the embodiment of Figure 2 no inner core or reinforcement is provided within stainless steel coil 36. Threadlike portion 18 is provided in the embodiment of Figure 1 to allow increased tensile strength of the guidewire. However, a degree of flexibility of the guidewire is sacrificed by the inclusion even of threadlike tip 18, so that the embodiment of Figure 2 provides a more flexible tip, at least for that portion of the microguidewire constituting the stainless steel coil 36.
0054It is expressly understood that the helical secondary coil tip of the embodiment of Figure 1 could similarly be attached to stainless steel coil 36 of the embodiment of Figure 2 without departing from the spirit and scope of the invention.
0055Thinned and threadlike portion guidewires disposed concentrically within coiled portions are well known and are shown in <b>Antoshkiw</b>, "Disposable Guidewire", U.S. Patent 3,789,841 (1974); <b>Sepetka</b> et al., "Guidewire Device", U.S. Patent 4,832,047 (1989); <b>Engleson</b>, "Catheter Guidewire", U.S. Patent 4,884,579 (1989); <b>Samson</b> et al., "Guidewire for Catheters", U.S. Patent 4,538,622 (1985); and <b>Samson</b> et al., "Catheter Guidewire with Short Spring Tip and Method of Using the Same", U.S. Patent 4,554,929 (1985).
0056Turn now to the third embodiment of the invention as shown in Figure 3. Figure 3 shows an enlarged side view of a guidewire, generally denoted by reference numeral 42, disposed within a microcatheter 44 shown in cross-sectional view. Like the embodiment of Figure 1, a stainless steel coil 46 is soldered to a conical portion 48 of guidewire 22 at a first bonding location 50. A thin threadlike extension 52 is then longitudinally disposed within stainless steel coil 46 to a second bonding location 54 where stainless steel guidewire 46 and threadlike portion 52 are soldered to a soft platinum coil 56. Platinum coil 56 is not prebiased, nor does it contain any internal reinforcement, but is a free and open coil similar in that respect to stainless steel coil 36 of the embodiment of Figure 2.
0057However, platinum coil 56 is particularly distinguished by its length of approximately 1 to 50 cm. and by its flexibility. The platinum or platinum alloy used is particularly pliable and the diameter of the wire used to form platinum coil 56 is approximately 0.001 - 0.005 inch in diameter. The distal end of platinum coil 56 is provided with a smooth and rounded platinum tip 58 similar in that respect to tips 30 and 40 of Figures 1 and 2, respectively.
0058When coil 56 is disposed within microcatheter 54, it lies along the longitudinal lumen 60 defined by microcatheter 44. The distal end 62 of microcatheter 60 is then placed into the neck of the aneurysm and the guidewire 42 is advanced, thereby feeding tip 58 in platinum coil 56 into aneurysm 64 until bonding location 50 resides in the neck of the aneurysm as best depicted in the diagrammatic cross-sectional view of Figure 4.
0059Figure 4 illustrates the insertion of the embodiment of Figure 3 within a vessel 66 with distal tip of microcatheter 44 positioned near neck 68 of aneurysm 64. Coil 56 is fed into aneurysm 64 until at least a portion of stainless steel coil 46 is exposed beyond the distal tip 62 of microcatheter 44. A positive electric current of approximately 0.01 to 2 milliamps at 0.1 - 6 volts is applied to guidewire 42 to form the thrombus. Typically a thrombus will form within three to five minutes. The negative pole 72 of voltage source 70 is typically placed over and in contact with the skin.
0060After the thrombus has been formed and the aneurysm completely occluded, tip 58 and coil 56 are detached from guidewire 42 by electrolytic disintegration of at least one portion of stainless steel coil 46. In the illustrated embodiment this is accomplished by continued application of current until the total time of current application is almost approximately four minutes.
0061At least one portion of stainless steel coil 46 will be completely dissolved through by electrolytic action within 3 to 10 minutes, usually about 4 minutes. After separation by electrolytic disintegration, guidewire 42, microcatheter 44 and the remaining portion of coil 46 still attached to guidewire 42 are removed from vessel 66, leaving aneurysm 64 completely occluded as diagrammatically depicted in Figure 5 by thrombus 74. It will be appreciated that the time of disintegration may be varied by altering the dimensions of the portions of the wire and/or the current.
0062The process is practiced under fluoroscopic control with local anesthesia at the groin. A transfemoral microcatheter is utilized to treat the cerebral aneurysm. The platinum is not affected by electrolysis and the remaining portions of the microcatheter are insulated either by a Teflon lamination directly on guidewire 42 and/or by microcatheter 44. Only the exposed portion of the guidewire 46 is affected by the electrolysis.
0063It has further been discovered that thrombus 74 continues to form even after detachment from guidewire 42. It is believed that a positive charge is retained on or near coil 56 which therefore continues to attract platelets, white blood cells, red blood cells and fibrinogen within aneurysm 64.
0064Many alterations and modifications may be made by those having ordinary skill in the art without departing from the spirit and scope of the invention. Therefore, it must be understood that the shape of the tip or distal platinum coil used in combination with the guidewire according to the invention may be provided with a variety of shapes and envelopes. In addition thereto, the composition of the microguidewire tip may be made of elements other than platinum including stainless steel, beryllium, copper and various alloys of the same with or without platinum. Still further, the diameter of the guidewire, various of the guidewire described above and the stainless steel coil immediately proximal to the detachable tip may be provided with differing diameters or cross sections to vary the times and current magnitudes necessary in order to effectuate electrolytic detachment from the tip. Still further, the invention may include conventional electronics connected to the proximal end of the guidewire for determining the exact instant of detachment of the distal tip from the guidewire.
0065Therefore, the illustrated embodiment has been set forth only for the purposes of clarity and example and should not be taken as limiting the invention as defined by the following claims, which include all equivalent means whether now known or later devised.
6 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2009073398A1 | Cited by | World Intellectual Property Organization (WIPO) | – | International search | – |
| US10342683B2 | Cited by | United States of America | – | Applicant | – |
| US10456151B2 | Cited by | United States of America | – | Applicant | – |
| US10722255B2 | Cited by | United States of America | – | Applicant | – |
| US10413310B2 | Cited by | United States of America | – | Applicant | – |
| US11304712B2 | Cited by | United States of America | – | Applicant | – |
| USRE41029E | Cited by | United States of America | – | Applicant | – |
| US10426644B2 | Cited by | United States of America | – | Applicant | – |
| USRE41029E1 | Cited by | United States of America | – | Applicant | – |
| US11426293B2 | Cited by | United States of America | – | Applicant | – |
| US10076399B2 | Cited by | United States of America | – | Applicant | – |
| DE3203410A1 | Cites | Germany | A | Search report | 1,26 |
| US4522205A | Cites | United States of America | A | Search report | 1,26 |
| US4748986A | Cites | United States of America | A | Search report | 1-3,9,10,18,23,26 |
| WO8404686A1 | Cites | World Intellectual Property Organization (WIPO) | A | Search report | 1,5,6,26 |
182 members in 18 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 492717 | United States of America | – | |
| 49271790 | United States of America | A | |
| 91905194 | European Patent Office (EPO) | A |
Members182
| Document | Office | Kind | |
|---|---|---|---|
| CA2055492A1 | Canada | A1 | |
| WO9113592A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7447491A | Australia | A | |
| FI915332A7 | Finland | A7 | |
| NO914433D0 | Norway | D0 | |
| NO914433L | Norway | L | |
| HU9103536D0 | Hungary | D0 | |
| EP0484468A1 | European Patent Office (EPO) | A1 | |
| US5122136A | United States of America | A | |
| KR920700586A | Republic of Korea | A | |
| JPH05500322A | Japan | A | |
| AU636217B2 | Australia | B2 | |
| NO20056147L | Norway | L | |
| CA2120779A1 | Canada | A1 | |
| WO9316650A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2801692A | Australia | A | |
| PT101162A | Portugal | A | |
| FI941937A | Finland | A | |
| FI941937A7 | Finland | A7 | |
| EP0484468A4 | European Patent Office (EPO) | A4 | |
| NO943106D0 | Norway | D0 | |
| NO943106L | Norway | L | |
| US5354295A | United States of America | A | |
| EP0629125A1 | European Patent Office (EPO) | A1 | |
| JPH07503165A | Japan | A | |
| HUT68240A | Hungary | A | |
| EP0629125A4 | European Patent Office (EPO) | A4 | |
| ES2074406T1 | Spain | T1 | |
| DE484468T1 | Germany | T1 | |
| IL115609D0 | Israel | D0 | |
| CA2160640A1 | Canada | A1 | |
| EP0707830A1 | European Patent Office (EPO) | A1 | |
| AU3429195A | Australia | A | |
| JP2501389B2 | Japan | B2 | |
| NO962745D0 | Norway | D0 | |
| US5540680A | United States of America | A | |
| JPH08196544A | Japan | A | |
| US5569245A | United States of America | A | |
| AU673502B2 | Australia | B2 | |
| CA2179863A1 | Canada | A1 | |
| EP0750886A1 | European Patent Office (EPO) | A1 | |
| NO962745L | Norway | L | |
| AU5624496A | Australia | A | |
| KR970000269A | Republic of Korea | A | |
| JPH0998981A | Japan | A | |
| EP0800790A2 | European Patent Office (EPO) | A2 | |
| EP0800790A3 | European Patent Office (EPO) | A3 | |
| EP0803230A2 | European Patent Office (EPO) | A2 | |
| EP0804904A1 | European Patent Office (EPO) | A1 | |
| EP0804905A1This record | European Patent Office (EPO) | A1 | |
| EP0804906A2 | European Patent Office (EPO) | A2 | |
| EP0803230A3 | European Patent Office (EPO) | A3 | |
| EP0804906A3 | European Patent Office (EPO) | A3 | |
| GR980300008T1 | Greece | T1 | |
| DE804904T1 | Germany | T1 | |
| EP0629125B1 | European Patent Office (EPO) | B1 | |
| AT167617T | Austria | T | |
| ATE167617T1 | Austria | T1 | |
| DE69226024D1 | Germany | D1 | |
| TW340793B | Taiwan Province of China | B | |
| US5851206A | United States of America | A | |
| US5855578A | United States of America | A | |
| DE69226024T2 | Germany | T2 | |
| EP0804906B1 | European Patent Office (EPO) | B1 | |
| AT175334T | Austria | T | |
| ATE175334T1 | Austria | T1 | |
| DE69228134D1 | Germany | D1 | |
| US5895385A | United States of America | A | |
| AU704583B2 | Australia | B2 | |
| EP0914803A1 | European Patent Office (EPO) | A1 | |
| DE69228134T2 | Germany | T2 | |
| KR100200441B1 | Republic of Korea | B1 | |
| EP0484468B1 | European Patent Office (EPO) | B1 | |
| US5919187A | United States of America | A | |
| IL115609A | Israel | A | |
| AT181225T | Austria | T | |
| ATE181225T1 | Austria | T1 | |
| US5925037A | United States of America | A | |
| EP0800790B1 | European Patent Office (EPO) | B1 | |
| EP0804905B1 | European Patent Office (EPO) | B1 | |
| DE69131340D1 | Germany | D1 | |
| US5928226A | United States of America | A | |
| AT182260T | Austria | T | |
| AT182261T | Austria | T | |
| ATE182260T1 | Austria | T1 | |
| ATE182261T1 | Austria | T1 | |
| DE69131466D1 | Germany | D1 | |
| DE69131467D1 | Germany | D1 | |
| US5944714A | United States of America | A | |
| US5947962A | United States of America | A | |
| US5947963A | United States of America | A | |
| DE69131340T2 | Germany | T2 | |
| US5976126A | United States of America | A | |
| US5976131A | United States of America | A | |
| DE69131466T2 | Germany | T2 | |
| DE69131467T2 | Germany | T2 | |
| DK0484468T3 | Denmark | T3 | |
| CA2120779C | Canada | C | |
| DK0800790T3 | Denmark | T3 | |
| DK0804905T3 | Denmark | T3 |
50 legal events, as 5 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Discontinued because of reaching the maximum lifetime of a patentV4 | V4 | NL | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| New agentNV | NV | CH | |
| Modification of the scope of the patentDAS PATENT IST AUFGRUND DES WEITERBEHANDLUNGSANTRAGS VOM 15.12.1999 REAKTIVIERT WORDEN.AEN | AEN | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0804905
- Application
- 971111117
Titles3
- German
- Endovaskuläre elektrolytisch abtrennbare Führungsdrahtspitze
- English
- Endovascular electrolytically detachable guidewire tip
- French
- Extrémité de fil de guidage endovasculaire détachable de manière électrolytique
Classification
- CPC, 25
- A61M25/09
- A61B18/00
- A61B17/12022
- A61B17/12113
- A61B17/1214
- A61B17/12145
- A61B17/1215
- A61B18/1492
- A61B2017/00292
- A61B2017/12063
- A61B2017/22038
- A61B2018/00678
- A61B2018/00761
- A61B2018/00875
- A61B2018/00886
- A61B2018/1226
- A61B2018/1253
- A61B2018/126
- A61B2018/1266
- A61B2018/1435
- A61B2018/1495
- A61M2025/0042
- A61M2025/09175
- A61B90/39
- A61B2090/3966
- IPC, 7
- A61B18 00
- A61B17 00
- A61B17 12
- A61B18 12
- A61B18 14
- A61B19 00
- A61M25 00
Designated states1
- Contracting states, 1
- Sweden